Navigation Links
Cocaine high caused by interference in neuronal receiving stations

Researchers have found evidence for a fundamental molecular mechanism underlying the hyperactive high of cocaine. In studies with rats, they have traced the effect to interactions between two types of receiving stations in neurons for nerve signals from their neighbors. The researchers' studies in rats found that when the animals received cocaine, a component of a receptor for the neurotransmitter dopamine tends to grab onto a component of a receptor for glutamate. The result, they found, was interference with normal activation of this glutamate receptor.

John Wang, of the University of Missouri, Kansas City School of Medicine, and his colleagues published their findings in the December 7, 2006, issue of the journal Neuron, published by Cell Press.

Neurons trigger nerve impulses in their neighbors by launching bursts of chemicals called neurotransmitters at them. The neurotransmitters activate protein receptors on the receiving neurons, which induce the nerve impulses in the receiving cell. These receptors also adjust themselves in complex ways to alter the sensitivity of the receiving neuron to stimulation.

Researchers had long known that cocaine affects both dopamine and glutamate receptors on neurons, but the molecular details of those effects were unknown. In their experiments, Wang and colleagues first determined that cocaine reduces the activation of glutamate-responsive neurons by affecting a specific component, or subunit, of the receptor, called NR2B.

Further experiments revealed that when rats were given cocaine, a specific subunit of dopamine receptors, called D2R, tended to attach to the NR2B subunit and was responsible for preventing the normal activation of the glutamate receptor. Such activation normally involves addition to NR2B of a molecular group called a phosphate by an enzyme called a kinase, and the cocaine-induced D2R attachment blocked this event.

Wang and his colleagues found that this interaction between D2R and NR2B occurred specifically in the striatum of the brain—the region known to be responsible for cocaine's stimulating effects.

The researchers also analyzed whether this interaction between D2R and NR2B affected the rats' behavioral response to cocaine—specifically the hyperactivity and intensive sniffing and biting the drug elicits in the animals. They found that drugs that either activated the D2R subunit or inactivated the NR2B subunit tended to enhance such behavioral responses to cocaine.

"These results provide strong evidence supporting a critical role of the D2R-NR2B interaction in mediating cocaine's effect on [kinase binding and phosphorylation] and in constructing a full-scale motor response to cocaine," concluded the researchers.


Source:Cell Press

Related biology news :

1. Potential Drug Target For Treating Cocaine Abuse Found
2. Comparison of Cocaine, Methamphetamine ‘Highs?Finds Differences
3. Disrupting Cocaine-memories To Battle Addiction
4. UNC launches study of liver injury caused by drugs
5. Oxygen increase caused mammals to triumph, researchers say
6. Blocking the nerve receptor EP1 in mouse models reduces brain damage caused by stroke
7. Stem cell mobilization therapy appears to be ineffective in repairing damage caused by heart attack
8. Whiplash injuries ?are they caused by startle reflexes?
9. Man may have caused pre-historic extinctions
10. Scientists discover new virus caused deaths of transplant recipients from single donor
11. New study may show how to forestall a fatal, virus-caused immune-system meltdown
Post Your Comments:

(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... 2016 adds 2016 ... its pharmaceuticals section with historic and forecast data ... more. Complete report on the Cell ... 15 companies and supported with 261 tables and ... . The Global Cell Culture Media ...
Breaking Biology Technology: